Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Society of Gynecologic Oncology, SGO, Precision Medicine, Genetics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Force, Bright Pink

Medical Societies, Advocacy Groups Develop Genetics Toolkit

The Society of Gynecologic Oncology (SGO) convened experts from the American College of Obstetricians and Gynecologists (ACOG), National Society of Genetic Counselors, Bright Pink and Facing Our Risk of Cancer Empowered (FORCE), to develop the SGO Genetics Toolkit.

Medicine

Channels:

Society of Gynecologic Oncology, Ovarian Cancer, American Society of Clinical Oncology

ASCO and SGO Issue New Guidelines for Treating Ovarian Cancer

The American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) jointly issued new clinical practice guidelines for the treatment of patients with ovarian cancer.1

Medicine

Channels:

SGO Annual Meeting, Society of Gynecologic Oncology, Jeffrey Fowler

Dr. Jeffrey Fowler Begins SGO Presidency

Fowler_Jeffrey.jpg

effrey Fowler, MD, John G. Boutselis Chair in Gynecologic Oncology and Professor and vice-chair of Obstetrics and Gynecology at The Ohio State University Wexner Medical Center in Columbus, started his one-year term as the 48th President of the Society of Gynecologic Oncology (SGO) today at the conclusion of the Society’s 47th Annual Meeting on Women’s Cancer in San Diego.

Medicine

Channels:

SGO, SGO Annual Meeting, Society of Gynecologic Oncology

Dr. Michael Birrer Named Recipient of the 2016 Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher

Birrerphoto.jpg

The Claudia Cohen Research Foundation and the Foundation for Women’s Cancer announced today that Michael J. Birrer, MD, PhD, has been selected as the 2016 recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher.

Medicine

Channels:

SGO, Society of Gynecologic Oncology

SGO Names New CEO for Society and Foundation

The Society of Gynecologic Oncology has appointed Pierre M. Désy, MPH, CAE, as Chief Executive Officer of the Society and its Foundation for Women’s Cancer, effective April 25, 2016.

Medicine

Channels:

SGO’s Foundation for Gynecologic Oncology Merges with Foundation for Women’s Cancer

Gynecologic oncology research, education and awareness took a historic step forward on Jan. 1, 2016, when the Society of Gynecologic Oncology’s Foundation for Gynecology Oncology and the Foundation for Women’s Cancer (FWC) became one foundation within the SGO.

Medicine

Channels:

Society of Gynecologic Oncology, SGO, SGO Annual Meeting

Dr. Robert Coleman Begins SGO and Foundation Presidency

ColemanOfficialPhotoforPresidency2015.jpg

Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, has started his one-year term as the 47th President of the Society of Gynecologic Oncology (SGO) and fifth President of the Foundation for Gynecologic Oncology.

Medicine

Channels:

Society of Gynecologic Oncology, SGO, SGO Annual Meeting, Ovarian Cancer, Immunotherapy

Immunotherapy Delays Recurrence for Stage III and IV Ovarian Cancers

Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the cancer’s return.

Medicine

Channels:

Society of Gynecologic Oncology, American Society for Colposcopy and Cervical Pathology, HPV, FDA, Cervical Cancer, Cervical Cancer Screening, ATHENA Study

Medical Societies Recommend Consideration of Primary HPV Testing for Cervical Cancer Screening

Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing with cytology and HPV testing.

Medicine

Channels:

Hpv Vaccine, Society of Gynecologic Oncology, FDA Approval

FDA Approval of Nonavalent HPV Vaccine Adds New Tool to Eradicate Cervical Cancer

The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to the Society of Gynecologic Oncology (SGO).







Chat now!